Mednax Stock Hits New 52-Week High (MD)

NEW YORK ( TheStreet) -- Mednax (NYSE: MD) hit a new 52-week high Friday as it is currently trading at $75.53, above its previous 52-week high of $75.47 with 145,945 shares traded as of 12:30 p.m. ET. Average volume has been 328,600 shares over the past 30 days.

Mednax has a market cap of $3.49 billion and is part of the health care sector and health services industry. Shares are up 3.2% year to date as of the close of trading on Thursday.

MEDNAX, Inc. provides neonatal, maternal-fetal, other pediatric subspecialty, and anesthesia physician services in the United States and Puerto Rico. The company has a P/E ratio of 16.5, above the average health services industry P/E ratio of 16.2 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Mednax as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, solid stock price performance and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full Mednax Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Dow Rises for First Time in 9 Days, Oil Jumps as OPEC Agrees to Boost Output

Dow Rises for First Time in 9 Days, Oil Jumps as OPEC Agrees to Boost Output

German Automakers Slump After Trump Tweets New Tariff Threat

German Automakers Slump After Trump Tweets New Tariff Threat

Chipotle Rises After Wedbush Lifts Price Target

Chipotle Rises After Wedbush Lifts Price Target

Crude Rises on OPEC Deal That Doesn't Specify Output Boost

Crude Rises on OPEC Deal That Doesn't Specify Output Boost

Video: Stock Investors Shouldn't Fret About Oil Prices in the $60s

Video: Stock Investors Shouldn't Fret About Oil Prices in the $60s